Summary
Behavioral models have been used extensively in the development and evaluation of anxiolytic drugs. The introduction of clinically-effective anxiolytic drugs that appear to function through mechanisms other than those related to benzodiazepine (BZ) compounds has resulted in a critical re-evaluation of traditional models and concepts of anxiety, as well as the introduction of new animal models. This chapter provides an overview and evaluation of current animal behavior models used in the analysis of anxiolytic drugs with a focus on novel anxiolytics acting through serotonin (5-HT) receptor systems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Ator, N.A., Cook, J.M., Griffiths, R.R. (1989) Drug Dev. Res. 16, 257–267.
Barrett, J.E., Witkin, J.M., Mansbach, R.S., Skolnick, P., Weissman, B.A. (1986) J. Pharmacol. Exp. Ther. 238, 1009–1013.
Barrett, J.E., Gleeson, S., Nader, M.A., Hoffmann, S.M. (1989) J. Psychopharmacol. 3, 64–69.
Barrett, J.E., Witkin, J.M. (1990) In: Buspirone: Mechanisms and Clinical Aspects (G. Tunnicliff, A.S. Eison and D.P. Taylor, Eds), Academic Press/Tampa, FL.
Benjamin, D., Lal, H., Meyerson, L.R. (1990) Life Sci. 47, 195–203.
Blanchard, D.C., Rodgers, R.J., Hendrie, CA., Hori, K. (1988) Pharmacol. Biochem. Behav. 31, 269–278.
Brady, L.S., Barrett, J.E. (1985) J. Pharmacol. Exp. Ther. 234, 106–112.
Brocco, M.J., Koek, W., Degryse, A.-D., Colpaert, F.C. (1990) Behav. Pharmacol. 1.
Broekkamp, C.L.E., Berendsen, H.H.G., Jenck, F., Van Delft, A.M.L. (1989) Psychopathology 22 (suppl. 1), 2–12.
Cappell, H.D., LeBlanc, A.E. (1973) J. Comp. Physiol. Psychol. 83, 97–104.
Carli, M., Prontera, C, Samanin, R. (1989) Br. J. Pharmacol. 96, 829–836.
Carli, M., Samanin, R. (1988) Psychopharmacology 94, 84–91.
Chopin, P., Briley, M. (1987) Trends Pharmacol. Sci. 8, 383–388.
Charney, D.S., Woods, S.W., Goodman, W.K., Heninger, G.R. (1987) Psychopharmacology 92, 14–24.
Colpaert, F.C., Meert, T.F., Niemegeers, C.J.E., Janssen, P.A.J. (1985) Psychopharmacology 86, 45–54.
Costall, B., Domeney, A.M., Gerrard, P.A., Kelly, M.E., Naylor, R.J. (1988a) J. Pharm. Pharmacol. 40, 302–305.
Costall, B., Jones, B.J., Kelly, M.E., Naylor, R.J., Tomkins, D.M. (1989) Pharmacol. Biochem. Behav. 32, 777–785.
Costall, B., Kelly, M.E., Naylor, R.J., Onaivi, E.S. (1988b) J. Pharm. Pharmacol. 40, 494–500.
Craft, R.M., Howard, J.L., Pollard, G.T. (1988) Pharmacol. Biochem. Behav. 30, 775–780.
Crawley, J.N. (1985) Neurosci. Biobehav. Rev. 9, 37–44.
Critchley, M.A.E., Handley, S.L. (1987) Psychopharmacology 93, 502–506.
Cutler, M.G. (1990) Neuropharmacol. 29, 515–520.
Davis, M. (1988) Anim. Models Psychiaf. Disord. 1, 61–89.
Davis, M., Cassella, J.V., Kenne, J.H. (1988) Psychopharmacology 94, 14–20.
Dunn, R.W., Corkett, R., Fielding, S. (1989) Eur. J. Pharmacol. 169, 1–10.
Engel, J.A., Hjorth, S., Svensson, K., Carlsson, A., Liljequist, S. (1984). Eur. J. Pharmacol. 105, 365–368.
Ervin, G.N., Cooper, B.R. (1988) J. Pharmacol. Exp. Ther. 245, 137–146.
Ervin, G.N., Soroko, F.S., Cooper, B.R. (1987) Drug. Dev. Res. 11, 87–95.
Fernández-Guasti, A., Lopez-Rubalcava, C. (1990) Psychopharmacology 101, 354–358.
File, S. (1985) Neuropsychobiology 13, 55–62.
File, S. (1988) Anim. Models Psychiat. Disord. 1, 151–166.
File, S., Johnston, A.L. (1989) Psychopharmacology 99, 248–251.
Gardner, C.R. (1985) J. Pharmacol. Meth. 14, 181–187.
Gardner, C.R. (1986) Pharmacol. Biochem. Behav. 24, 1479–1485.
Gardner, C.R. (1988) Gen. Pharmac. 19, 347–356.
Geller, I., Hartmann, R.J. (1982) J. Clin. Psychiatry 43, 25–32.
Geller, I., Seifter, J. (1960) Psychopharmacologia 1, 782–492.
Gleeson, S., Ahlers, S.T., Mansbach, R.S., Foust, J.M., Barrett, J.E. (1989) J. Pharmacol. Exp. Ther. 250, 809–817.
Gleeson, S., Barrett, J.E. (1990) Pharmacol. Biochem. Behav. 37, 335–337.
Glenn, B., Green, S. (1989) Behav. Pharmacol. 1, 91–94.
Goa, K.L., Ward, A. (1986) Drugs 32, 114–129.
Goldberg, M.E., Salama, A.I., Patel, J.B., Malick, J.B. (1983) Neuropharmacology 22, 1499–1504.
Gower, A.J., Tricklebank, M.D. (1988) Eur. J. Pharmacol. 155, 129–137.
Graeff, F. (1987) In: Advances in Behavioral Pharmacology (T. Thompson, P.B. Dews and J.E. Barrett, Eds), Lawrence Erlbaum/Hillsdale, NJ, pp 129–156.
Guy, A.P., Gardner, C.R. (1985) Neuropsychobiology 13, 194–200.
Hård, E., Engel, J. (1988) Neuropharmacol. 27, 981–986.
Hodges, H., Green, S., Glenn, B. (1987) Psycfiopharmacology 92, 491–504.
Howard, J.L., Nanry, K.P., Perkins, A.N., Thomas, J.D. (1990) Faseb J. 4, A616.
Howard, J.L., Pollard, G.T. (1990) Drug Dev. Res. 19, 37–49.
Insel, T.R., Gelhard, R.E., Miller, L.P. (1990) Dev. Psychobiol. 22, 509–525.
Jenck, F., Broekkamp, C.L.E., Van Delft, A.M.L. (1989a) Psycfiopharmacology 97, 489–495.
Jenck, F., Broekkamp, C.L.E., Van Delft, A.M.L. (1989b) Eur. J. Pharmacol. 161, 219–221.
Jenck, F., Broekkamp, C.L.E., Van Delft, A.M.L. (1990a) Psychopharmacology 100, 372–376.
Jenck, F., Broekkamp, C.L.E., Van Delft, A.M.L. (1990b) Eur. J. Pharmacol. 197, 201–204.
Jones, B.J., Costall, B., Domeney, A.M., Kelly, M.E., Naylor, R.J., Oakley, N.R., Tyers, M.B. (1988) Br. J. Pharmacol. 93, 985–993.
Kennett, G.A., Whitton, P., Shah, K., Curzon, G. (1989) Eur. J. Pharmacol. 164, 445–454.
Kostowski, W., Plaznik, A., Stefanski, R. (1989) Eur. J. Pharmacol. 168, 393–396.
Lal, H., Emmett-Oglesby, M.W. (1983) Neuropharmacol. 22, 1423–1441.
Lecci, A., Borsini, F., Volterra, G., Meli, A. (1990) Psychopharmacology 101, 255–261.
Lister, R.G. (1990) Pharmac. Ther. 46, 321–340.
Mansbach, R.S., Geyer, M.A. (1988) Eur. J. Pharmacol. 156, 375–383.
Mansbach, R.S., Harrod, C, Hoffmann, S.M., Nader, M.A., Lei, Z., Witkin, J.M., Barrett, J.E. (1988) J. Pharmacol. Exp. Ther. 246, 114–120.
Mason, S.T., Skinner, J., Luttinger, D. (1987) Psychopharmacology 92, 30–34.
McCloskey, T.C., Paul, B.K., Commissaris, R.L. (1987) Pharmacol. Biochem. Behav. 27, 171–175.
Meert, T.F., Colpaert, F.C. (1986) Psychopharmacology 88, 445–450.
Meert, T.F., Janssen, P.A.J. (1989) Drug Dev. Res. 18, 119–144.
Merlo Pich, E.M., Samanin, R. (1986) Psychopharmacology 89, 125–130.
Mos, J., v.d. Heyden, J., Olivier, B. (1989) In: Behavioural Pharmacology of 5-HT (P. Bevan, A.R. Cools and T. Archer, Eds), Lawrence Erlbaum/Hillsdale, N.J., pp 389–395.
Mos, J., Olivier, B. (1989) In: Behavioural Pharmacology of 5-HT (P. Bevan, A.R. Cools and T. Archer, Eds), Lawrence Erlbaum/Hillsdale, N.J., pp 361–366.
Moser, P.C. (1989) Psychopharmacology 99, 48–53.
Moser, P.C., Tricklebank, M.D., Middlemiss, D.N., Mir, A.K., Hibert, M.F., Fozard, J.R. (1990) Br. J. Pharmacol. 99, 343–349.
Oakley, N.R., Jones, B.J. (1983) Eur. J. Pharmacol. 87, 499–500.
Olivier, B., Mos, J., Tulp, M., Schipper, J., Bevan, P. (1989) In: Behavioural Pharmacology of 5-HT (P. Bevan, A.R. Cools & T. Archer, Eds), Lawrence Erlbaum/Hillsdale, N.J., pp 89–115.
Onaivi, E.S., Martin, B.R. (1990) Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 13, 963–976.
Papp, M., Przegalinski, E. (1989) J. Psychopharmacol. 3, 14–20.
Pellow, S. (1986) Meth. Find. Exptl. Clin. Pharmacol. 8, 557–565.
Pellow, S., Chopin, P., File, S., Briley, M. (1985) J. Neurosci. Meth. 14, 149–167.
Pellow, S., File, S.E. (1986) Pharmacol. Biochem. Behav. 24, 525–529.
Pollard, G.T., Howard, J.L. (1990) Pharmacol. Ther. 45, 403–424.
Przegalinski, E., Tatarczynska and Chojnacka-Wójcik (1989) J. Psychopharmacol. 3, 180–185.
Rohmer, J.-G., Di Scala, G., Sander, G. (1990) Behav. Brain Res. 38, 45–54.
Sanger, D.J., Joly, D., Zivkovic, B. (1985) J. Pharmacol. Exp. Ther. 232, 831–837.
Schefke, D.M., Fontana, D.J., Commissaris, R.L. (1989) Psychopharmacology 99, 427–429.
Sepinwall, J. (1985) In: Behavioral Pharmacology: The Current Status (L.S. Seiden and R.L. Balster, Eds), Alan R. Liss/New York, pp. 181–203.
Shimizu, H., Hirose, A., Tatsuno, T., Nakamura, M., Katsube, J. (1987) Jap. J. Pharmacol. 45, 493–500.
Söderpalm, B., Rjorth, S., Engel, J.A. (1989) Pharmacol. Biochem. Behav. 32, 259–265.
Stephens, D.N., Kehr, W., Schneider, H.H., and Schmiechen, R. (1984) Neurosci. Lett. 47, 333–338.
Treit, D. (1985) Neurosci. Biobehav. Rev. 9, 203–222.
Treit, D. (1990) Pharmacol. Biochem. Behav. 36, 203–205.
Treit, D., Fundytus, M. (1988) Pharmacol. Biochem. Behav. 30, 1071–1075.
Vellucci, S.V., Martin, P.J., Everitt, B.J. (1988) J. Psychopharmacol. 2, 80–93.
Vogel, J.R., Beer, B., Clody, D.E. (1971) Psychopharmacologia 21, 1–7.
Weissman, B.A., Barrett, J.E., Brady, L.S., Witkin, J.M., Mendelson, W.B., Paul, S.M., Skolnick, P. (1984) Drug Dev. Res. 4, 83–93.
Wettstein, J.G. (1988) Eur. J. Pharmacol. 151, 341–344.
Winter, J.C. (1988) Pharmacol. Biochem. Behav. 29, 193–195.
Winter, J.C, Rabin, R.A. (1989) Drug. Dev. Res. 16, 327–333.
Witkin, J.M., Barrett, J.E. (1986) Pharmacol. Biochem. Behav. 24, 751–756.
Witkin, J.M., Perez, L.A. (1990) Behav. Pharm. 1, 247–254.
Young, R., Urbancic, A., Emrey, T.A., Hall, P.C., Metcalf, G. (1987) Eur. J. Pharmacol. 143, 361–371.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Basel AG
About this chapter
Cite this chapter
Barrett, J.E. (1991). Animal Behavior Models in the Analysis and Understanding of Anxiolytic Drugs Acting at Serotonin Receptors. In: Olivier, B., Mos, J., Slangen, J.L. (eds) Animal Models in Psychopharmacology. APS: Advances in Pharmacological Sciences. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-6419-0_3
Download citation
DOI: https://doi.org/10.1007/978-3-0348-6419-0_3
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-6421-3
Online ISBN: 978-3-0348-6419-0
eBook Packages: Springer Book Archive